Patents Assigned to GATEWAY BIOTECHNOLOGY, INC.
  • Methods and compositions for treating hearing disorders
    Patent number: 10434097
    Abstract: Disclosed herein are pharmaceuticals, compositions, kits, and methods for treating or preventing a hearing disorder in a subject in need thereof, wherein the pharmaceuticals, compositions, kits, and methods comprise administering a therapeutically effective amount of tetrandrine (TET) or a salt thereof.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: October 8, 2019
    Assignee: GATEWAY BIOTECHNOLOGY, INC.
    Inventors: Jianxin Bao, Xiaojie Chen